Abstract
Neuronal intranuclear inclusion disease (NIID) is a neurodegenerative disorder associated with GGC repeats of >60 to 500 copies in the 5′-untranslated region of NOTCH2NLC. The clinical and genetic characterization of NIID outside of East Asia remains unknown. We identified twelve patients who underwent genetic testing using long-read sequencing or repeat primed polymerase chain reaction. All were positive for a GGC repeat expansion; the median repeat length was 107 (range 92-138). Ten were Chinese and two of Malay ethnicity. Age at onset ranged from 50 to 69 years. Eight (66.7%) patients had dementia, while four (33.3%) patients were oligosymptomatic, without typical NIID symptoms of dementia, Parkinsonism, or muscle weakness. GGA interruptions within the GGC expansion were present in four patients; the number of GGA interruptions was highest (6.71%) in the patient with the earliest age at onset (50 years). Median plasma neurofilament light level was 47.3 pg/mL in seven patients (range 26-380 pg/mL). The highest level (380 pg/mL) was found in one patient who experienced an encephalitic episode. Overall, we describe a cohort of genetically confirmed NIID patients from Southeast Asia and provide further information that the presence of GGA interruptions within GGC repeat expansions may serve as a potential genetic modifier in NIID.
Original language | English |
---|---|
Pages (from-to) | 274-281 |
Number of pages | 8 |
Journal | Clinical Genetics |
Volume | 98 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sept 1 2020 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
ASJC Scopus Subject Areas
- Genetics
- Genetics(clinical)
Keywords
- diffusion-weighted imaging
- GGC repeat expansion
- neurofilament light
- neuronal intranuclear inclusion disease
- NOTCH2NLC